Analysis: The Market Has Oversold Shares Of Sabra Health Care REIT With A Catalyst On The Horizon


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


With Sabra Health Care REIT Inc (NASDAQ:SBRA) down 16.6 percent since it announced its purchase of Care Capital Properties Inc in May, JMP Securities sees a buying opportunity.

Analyst Peter Martin upgraded the stock Tuesday expecting a catalyst in Sabra’s upcoming investor call and pro-forma guidance as well as a 9-percent yield from its merger with Care Capital.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

The anticipated deal gains align with expectations from Egan-Jones and Glass Lewis, which in August urged investors to vote in approval in spite of opposing assessments. Eminence Capital and Hudson Bay Capital had earlier rejected the proposition, with the latter asserting that the $7.4 billion transaction “could prove fatally expensive” to shareholders.

“Based on this drastic decline in Sabra shareholder value, it is clear to us that the strategic rationale of the CCP Acquisition, as stated by Sabra management, has not been accepted by the market and the CCP Acquisition is not in the best interests of shareholders,” Hudson Bay wrote in a July open letter.

At its post-announcement nadir, Sabra had traded down 22.4 percent.

Mizuho Securities corroborated negative sentiments with a downgrade to Sell ━ notably, Sabra’s only such rating. The Street now has four Buys and three Holds on the stock, with recent upgrades from both Jefferies and JMP.

Martin maintains a $23 price target on the stock, foreseeing a 10-percent premium in net asset value representing discounts of 8-percent and 16-percent to industry peers Omega Healthcare Investors Inc (NYSE:OHI) and CareTrust REIT Inc (NASDAQ:CTRE).

At the time of publication, Sabra was trading at $22.43.

Related BZPro Headline: Shareholders of Sabra and Care Capital Properties, Respectively, Approve Merger

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Posted In: Analyst ColorREITUpgradesHealth CareAnalyst RatingsGeneralReal EstateJMP SecuritiesPeter Martin